Chemotherapy-free regimen induces 'high' clinical benefit rate in metastatic breast cancer healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Pembrolizumab demonstrated clinical activity among patients with diffuse malignant peritoneal mesothelioma, regardless of PD-L1 status or histology, according to data published in JAMA Network Open.
“In clinic, we have seen some people experience durable clinical benefit from pembrolizumab, so I was not surprised to find that we had a number of long-term responders,” Melina E.